T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
StoneX
SNEX
$7.84B
| $899K | ﹤0.01% |
54,867
+2,642
| +5% | +$45.2K |
|
1802
CryoPort
CYRX
$761M
| $896K | ﹤0.01% |
36,762
+1,051
| +3% | +$36.2K |
|
1803
Northwest Natural Holdings
NWN
$2.13B
| $894K | ﹤0.01% |
20,607
+3,163
| +18% | +$160K |
|
1804
Boot Barn
BOOT
$4.92B
| $892K | ﹤0.01% |
15,254
+4,033
| +36% | +$270K |
|
1805
Northwest Bancshares
NWBI
$2.31B
| $889K | ﹤0.01% |
65,793
-5,131
| -7% | -$71.4K |
|
|
HBI
1806
DELISTED
Hanesbrands
HBI
| $888K | ﹤0.01% |
127,572
+3,339
| +3% | +$32.8K |
|
1807
Newmark Group
NMRK
$2.74B
| $887K | ﹤0.01% |
109,943
+10,862
| +11% | +$112K |
|
1808
WaFd
WAFD
$2.8B
| $887K | ﹤0.01% |
29,563
-15,832
| -35% | -$513K |
|
1809
Southside Bancshares
SBSI
$985M
| $886K | ﹤0.01% |
25,041
+5,236
| +26% | +$201K |
|
1810
Upbound Group
UPBD
$1.14B
| $886K | ﹤0.01% |
50,582
+805
| +2% | +$20K |
|
1811
Liberty Global Class A
LBTYA
$3.62B
| $885K | ﹤0.01% |
56,729
| – | – |
|
1812
TTEC Holdings
TTEC
$79.9M
| $885K | ﹤0.01% |
19,952
+1,942
| +11% | +$116K |
|
|
VIVO
1813
DELISTED
Meridian Bioscience Inc
VIVO
| $884K | ﹤0.01% |
28,015
+1,336
| +5% | +$43.3K |
|
1814
ATN International
ATNI
$482M
| $882K | ﹤0.01% |
22,846
+3,495
| +18% | +$158K |
|
1815
Kennametal
KMT
$2.34B
| $877K | ﹤0.01% |
42,592
+8,704
| +26% | +$211K |
|
1816
Central Garden & Pet Co
CENT
$2.78B
| $876K | ﹤0.01% |
+30,350
| New | +$1.01M |
|
1817
Trinity Industries
TRN
$2.34B
| $875K | ﹤0.01% |
40,960
-26,130
| -39% | -$639K |
|
|
JWN
1818
DELISTED
Nordstrom
JWN
| $874K | ﹤0.01% |
52,205
-142
| -0.3% | -$2.96K |
|
1819
Playtika
PLTK
$942M
| $874K | ﹤0.01% |
93,040
-6,055,386
| -98% | -$69.8M |
|
1820
QCR Holdings
QCRH
$1.75B
| $873K | ﹤0.01% |
17,114
+968
| +6% | +$54.1K |
|
1821
Cohen & Steers
CNS
$4.39B
| $871K | ﹤0.01% |
13,899
-6,628
| -32% | -$474K |
|
1822
LGI Homes
LGIH
$1.37B
| $865K | ﹤0.01% |
10,622
-52,903
| -83% | -$5.18M |
|
|
NXGN
1823
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $865K | ﹤0.01% |
48,863
+3,808
| +8% | +$66.1K |
|
1824
Greif
GEF
$4.99B
| $862K | ﹤0.01% |
14,458
-4,515
| -24% | -$301K |
|
|
ODP
1825
DELISTED
ODP
ODP
| $862K | ﹤0.01% |
24,504
-808
| -3% | -$28.7K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.